Presynaptic Ca2+/calmodulin-dependent protein kinase II

Autophosphorylation and activity increase in the hippocampus after long-term blockade of serotonin reuptake

Maurizio Popoli, Claudia Vocaturo, Jorge Perez, Enrico Smeraldi, Giorgio Racagni

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

It is known that long-term treatment with antidepressants induces an enhancement of neurotransmission in the pathway projecting from raphe nuclei to the hippocampus. In the case of selective serotonin (5-HT) reuptake inhibitors, this enhancement is due to a desensitization of presynaptic 5-HT autoreceptors and a concomitant increase in 5-HT release in terminal areas. To investigate whether this effect is accompanied by adaptive changes in the molecular machinery regulating trans-mitter release at serotonergic terminals, autophosphorylation and activity of Ca2+/calmodulin-dependent protein kinase II were measured in subsynaptosomal fractions from hippocampus and total cortex. Long-term treatment with two selective serotonin reuptake inhibitors (paroxetine and fluvoxamine) and with a nonselective reuptake inhibitor (venlafaxine) induces a large increase of kinase autophosphorylation in synaptic vesicles and synaptic cytosol in the hippocampus but not in synaptosomal membranes. No significant change was detected in total cortex. The change is not reproduced by the direct addition of the drugs to the phosphorylation system and is not elicited by acute treatment of the animals. The increase in autophosphorylation is not accounted for by neosynthesis or translocation of the kinase to synaptic terminals. The change is restricted to the kinase located inside the terminals and is not detected in synaptosomal membranes, containing predominantly postsynaptic kinase, suggesting that only presynaptic kinase is affected. In the same fractions, the kinase activity is increased. These results are in agreement with reports suggesting a presynaptic effect for the SSRIs and disclose a new putative site of action for psychotropic drugs.

Original languageEnglish
Pages (from-to)623-629
Number of pages7
JournalMolecular Pharmacology
Volume48
Issue number4
Publication statusPublished - Oct 1995

Fingerprint

Calcium-Calmodulin-Dependent Protein Kinase Type 2
Hippocampus
Serotonin
Phosphotransferases
Fluvoxamine
Autoreceptors
Paroxetine
Raphe Nuclei
Membranes
Synaptic Vesicles
Psychotropic Drugs
Presynaptic Terminals
Serotonin Uptake Inhibitors
Synaptic Transmission
Cytosol
Antidepressive Agents
Phosphorylation
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology

Cite this

Presynaptic Ca2+/calmodulin-dependent protein kinase II : Autophosphorylation and activity increase in the hippocampus after long-term blockade of serotonin reuptake. / Popoli, Maurizio; Vocaturo, Claudia; Perez, Jorge; Smeraldi, Enrico; Racagni, Giorgio.

In: Molecular Pharmacology, Vol. 48, No. 4, 10.1995, p. 623-629.

Research output: Contribution to journalArticle

Popoli, Maurizio ; Vocaturo, Claudia ; Perez, Jorge ; Smeraldi, Enrico ; Racagni, Giorgio. / Presynaptic Ca2+/calmodulin-dependent protein kinase II : Autophosphorylation and activity increase in the hippocampus after long-term blockade of serotonin reuptake. In: Molecular Pharmacology. 1995 ; Vol. 48, No. 4. pp. 623-629.
@article{950621ae489a4a8bbc25752e6895fb68,
title = "Presynaptic Ca2+/calmodulin-dependent protein kinase II: Autophosphorylation and activity increase in the hippocampus after long-term blockade of serotonin reuptake",
abstract = "It is known that long-term treatment with antidepressants induces an enhancement of neurotransmission in the pathway projecting from raphe nuclei to the hippocampus. In the case of selective serotonin (5-HT) reuptake inhibitors, this enhancement is due to a desensitization of presynaptic 5-HT autoreceptors and a concomitant increase in 5-HT release in terminal areas. To investigate whether this effect is accompanied by adaptive changes in the molecular machinery regulating trans-mitter release at serotonergic terminals, autophosphorylation and activity of Ca2+/calmodulin-dependent protein kinase II were measured in subsynaptosomal fractions from hippocampus and total cortex. Long-term treatment with two selective serotonin reuptake inhibitors (paroxetine and fluvoxamine) and with a nonselective reuptake inhibitor (venlafaxine) induces a large increase of kinase autophosphorylation in synaptic vesicles and synaptic cytosol in the hippocampus but not in synaptosomal membranes. No significant change was detected in total cortex. The change is not reproduced by the direct addition of the drugs to the phosphorylation system and is not elicited by acute treatment of the animals. The increase in autophosphorylation is not accounted for by neosynthesis or translocation of the kinase to synaptic terminals. The change is restricted to the kinase located inside the terminals and is not detected in synaptosomal membranes, containing predominantly postsynaptic kinase, suggesting that only presynaptic kinase is affected. In the same fractions, the kinase activity is increased. These results are in agreement with reports suggesting a presynaptic effect for the SSRIs and disclose a new putative site of action for psychotropic drugs.",
author = "Maurizio Popoli and Claudia Vocaturo and Jorge Perez and Enrico Smeraldi and Giorgio Racagni",
year = "1995",
month = "10",
language = "English",
volume = "48",
pages = "623--629",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "4",

}

TY - JOUR

T1 - Presynaptic Ca2+/calmodulin-dependent protein kinase II

T2 - Autophosphorylation and activity increase in the hippocampus after long-term blockade of serotonin reuptake

AU - Popoli, Maurizio

AU - Vocaturo, Claudia

AU - Perez, Jorge

AU - Smeraldi, Enrico

AU - Racagni, Giorgio

PY - 1995/10

Y1 - 1995/10

N2 - It is known that long-term treatment with antidepressants induces an enhancement of neurotransmission in the pathway projecting from raphe nuclei to the hippocampus. In the case of selective serotonin (5-HT) reuptake inhibitors, this enhancement is due to a desensitization of presynaptic 5-HT autoreceptors and a concomitant increase in 5-HT release in terminal areas. To investigate whether this effect is accompanied by adaptive changes in the molecular machinery regulating trans-mitter release at serotonergic terminals, autophosphorylation and activity of Ca2+/calmodulin-dependent protein kinase II were measured in subsynaptosomal fractions from hippocampus and total cortex. Long-term treatment with two selective serotonin reuptake inhibitors (paroxetine and fluvoxamine) and with a nonselective reuptake inhibitor (venlafaxine) induces a large increase of kinase autophosphorylation in synaptic vesicles and synaptic cytosol in the hippocampus but not in synaptosomal membranes. No significant change was detected in total cortex. The change is not reproduced by the direct addition of the drugs to the phosphorylation system and is not elicited by acute treatment of the animals. The increase in autophosphorylation is not accounted for by neosynthesis or translocation of the kinase to synaptic terminals. The change is restricted to the kinase located inside the terminals and is not detected in synaptosomal membranes, containing predominantly postsynaptic kinase, suggesting that only presynaptic kinase is affected. In the same fractions, the kinase activity is increased. These results are in agreement with reports suggesting a presynaptic effect for the SSRIs and disclose a new putative site of action for psychotropic drugs.

AB - It is known that long-term treatment with antidepressants induces an enhancement of neurotransmission in the pathway projecting from raphe nuclei to the hippocampus. In the case of selective serotonin (5-HT) reuptake inhibitors, this enhancement is due to a desensitization of presynaptic 5-HT autoreceptors and a concomitant increase in 5-HT release in terminal areas. To investigate whether this effect is accompanied by adaptive changes in the molecular machinery regulating trans-mitter release at serotonergic terminals, autophosphorylation and activity of Ca2+/calmodulin-dependent protein kinase II were measured in subsynaptosomal fractions from hippocampus and total cortex. Long-term treatment with two selective serotonin reuptake inhibitors (paroxetine and fluvoxamine) and with a nonselective reuptake inhibitor (venlafaxine) induces a large increase of kinase autophosphorylation in synaptic vesicles and synaptic cytosol in the hippocampus but not in synaptosomal membranes. No significant change was detected in total cortex. The change is not reproduced by the direct addition of the drugs to the phosphorylation system and is not elicited by acute treatment of the animals. The increase in autophosphorylation is not accounted for by neosynthesis or translocation of the kinase to synaptic terminals. The change is restricted to the kinase located inside the terminals and is not detected in synaptosomal membranes, containing predominantly postsynaptic kinase, suggesting that only presynaptic kinase is affected. In the same fractions, the kinase activity is increased. These results are in agreement with reports suggesting a presynaptic effect for the SSRIs and disclose a new putative site of action for psychotropic drugs.

UR - http://www.scopus.com/inward/record.url?scp=0028970641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028970641&partnerID=8YFLogxK

M3 - Article

VL - 48

SP - 623

EP - 629

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 4

ER -